Coronary heart disease in Indians: implications of the INTERHEART study

Indian J Med Res. 2010 Nov;132(5):561-6. doi: 10.4103/0971-5916.73396.

Abstract

Coronary heart diseases (CHD) have reached epidemic proportions among Indians. The recently concluded INTERHEART study emphasizes the role of behavioural and conventional risk factors in the prediction of CHD risk among Indians. These findings have implication for the health care providers and policy makers in the country due to the fact that all these conventional risk factors are potentially modifiable and are good starting points for prevention. The policy measures by means of legislation and regulatory approaches on agriculture and food industry or tobacco or physical activity will have large impact on CHD risk factor reduction in the population. In addition, the health system needs to focus on: (i) providing information for increasing awareness and an enabling environment for adoption of healthy living habits by the community; (ii) early detection of persons with risk factors and cost-effective interventions for reducing risk; and (iii) early detection of persons with clinical disease and cost-effective secondary prevention measures to prevent complications. The evidence from INTERHEART provides rationale for developing treatment algorithms and treatment guidelines for CHD at various levels of health care. In addition, INTERHEART provides answer for the quest for a single reliable biomarker, Apo B/ApoA 1 ratio that can predict the future CHD risk among individuals. Further to this, the INTERHEART study also opens up several unanswered questions on the pathobiology of the premature onset of myocardial infarction among Indians and calls for the need to developing capacity in clinical research in CHD in India.

Publication types

  • Review

MeSH terms

  • Apolipoprotein A-I / blood
  • Apolipoproteins B / blood
  • Biomarkers / blood
  • Coronary Disease / epidemiology*
  • Coronary Disease / prevention & control*
  • Humans
  • India / epidemiology
  • Life Style
  • Practice Guidelines as Topic
  • Primary Prevention / legislation & jurisprudence
  • Primary Prevention / methods*
  • Public Policy*
  • Risk Factors

Substances

  • Apolipoprotein A-I
  • Apolipoproteins B
  • Biomarkers